NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hoba Therapeutics

Hoba Therapeutics

Private
CopenhagenHealthcare & Life Scienceshttps://hobatherapeutics.com

Last Round

Series A

Dec 11, 2023

Total Funding Raised

$30.95M

Company Overview

Hoba Therapeutics is a biotechnology company that develops novel therapeutic proteins for the treatment of chronic neuropathic pain and sensorineural hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologytherapeutic proteinsneuropathic painsensorineural hearing lossdrug discoverynon-opioid pain reliefbiopharmapreclinical developmentprotein therapeuticsdrug licensingpain managementhearing loss treatmentbiotech startupR&D pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hoba Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Hoba Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hoba Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 11, 2023
GrantJun 16, 2021
GrantSep 20, 2018
SeedNov 1, 2016

Key People

Founding team and executive leadership

Kenneth Ahrend Petersen

COO and Founder

Founding Team

Mikkel Dybkjær

CFO

Executive Team

Hoba Therapeutics Investors

Notable investors and investment history

Hoba Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hoba Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hoba Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range5
Year Founded2016
Last FundingDec 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.